Clinical trial
A Phase I Double-blinded, Placebo-controlled, Randomized Trial in HIV-uninfected, Healthy Adult Volunteers to Evaluate the Safety and Immunogenicity of an Adjuvanted GSK HIV Vaccine Administered With Ad35-GRIN Investigational Vaccine
NCT01264445 is registered in ClinicalTrials.gov with International AIDS Vaccine Initiative as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Double-blinded, Placebo-controlled, Randomized Trial in HIV-uninfected, Healthy Adult Volunteers to Evaluate the Safety and Immunogenicity of an Adjuvanted GSK HIV Vaccine Administered With Ad35-GRIN Investigational Vaccine
- Lead sponsor
- International AIDS Vaccine Initiative
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- November 30, 2012
- Enrollment
- 147 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.